At Work With: Augé Reichenberg

Augé Reichenberg
Augé Reichenberg
AUGÉ REICHENBERG
Executive Creative Director for ­Healthcare, Rosetta

What was your biggest break?
Probably when my first ­Creative Director turned me from being an art director into a copywriter.

What's the best and/or worst part of your job?
The best part of my job is being creative and getting paid for something I would do even if they didn't pay me.
 
What's the view like from your office/work area?
I overlook Fifth Avenue and a bit of sky, and am so thankful.

Does your office have a favorite lunch and/or after-hours place?
I'm too new at my current place to say. At my last agency, it was the Empire Room, a throwback to the Mad Men era.
 
What was your greatest professional challenge?
I led a team that created a consumer healthcare website in 10 days, and updated 200 pieces of an entire healthcare campaign in a month.
 
Where will you be in five years?
Running healthcare creative, but on a global scale.

If you were to write a book, what would the title be?
Give Life All You've Got or The Madwoman of Healthcare.
You must be a registered member of MMM to post a comment.
close

Next Article in Careers

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.